IMRX
Price
$4.06
Change
+$0.06 (+1.50%)
Updated
Jul 25 closing price
Capitalization
146.1M
10 days until earnings call
INSM
Price
$103.95
Change
+$0.43 (+0.42%)
Updated
Jul 25 closing price
Capitalization
19.75B
11 days until earnings call
Interact to see
Advertisement

IMRX vs INSM

Header iconIMRX vs INSM Comparison
Open Charts IMRX vs INSMBanner chart's image
Immuneering
Price$4.06
Change+$0.06 (+1.50%)
Volume$212.05K
Capitalization146.1M
Insmed
Price$103.95
Change+$0.43 (+0.42%)
Volume$1.4M
Capitalization19.75B
IMRX vs INSM Comparison Chart in %
Loading...
IMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INSM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMRX vs. INSM commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMRX is a Hold and INSM is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (IMRX: $4.06 vs. INSM: $103.95)
Brand notoriety: IMRX and INSM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMRX: 13% vs. INSM: 36%
Market capitalization -- IMRX: $146.1M vs. INSM: $19.75B
IMRX [@Biotechnology] is valued at $146.1M. INSM’s [@Biotechnology] market capitalization is $19.75B. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMRX’s FA Score shows that 0 FA rating(s) are green whileINSM’s FA Score has 1 green FA rating(s).

  • IMRX’s FA Score: 0 green, 5 red.
  • INSM’s FA Score: 1 green, 4 red.
According to our system of comparison, INSM is a better buy in the long-term than IMRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMRX’s TA Score shows that 4 TA indicator(s) are bullish while INSM’s TA Score has 4 bullish TA indicator(s).

  • IMRX’s TA Score: 4 bullish, 5 bearish.
  • INSM’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both IMRX and INSM are a bad buy in the short-term.

Price Growth

IMRX (@Biotechnology) experienced а -1.69% price change this week, while INSM (@Biotechnology) price change was +1.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.60%. For the same industry, the average monthly price growth was +17.32%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

IMRX is expected to report earnings on Aug 06, 2025.

INSM is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+7.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INSM($19.7B) has a higher market cap than IMRX($146M). IMRX YTD gains are higher at: 84.545 vs. INSM (50.565). IMRX has higher annual earnings (EBITDA): -63.85M vs. INSM (-917.87M). INSM has more cash in the bank: 1.2B vs. IMRX (35.9M). IMRX has less debt than INSM: IMRX (4.08M) vs INSM (1.14B). INSM has higher revenues than IMRX: INSM (381M) vs IMRX (0).
IMRXINSMIMRX / INSM
Capitalization146M19.7B1%
EBITDA-63.85M-917.87M7%
Gain YTD84.54550.565167%
P/E RatioN/AN/A-
Revenue0381M-
Total Cash35.9M1.2B3%
Total Debt4.08M1.14B0%
FUNDAMENTALS RATINGS
INSM: Fundamental Ratings
INSM
OUTLOOK RATING
1..100
5
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
PROFIT vs RISK RATING
1..100
10
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMRXINSM
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 3 days ago
81%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
72%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
72%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
75%
Advances
ODDS (%)
Bullish Trend 26 days ago
87%
Bullish Trend 3 days ago
69%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 10 days ago
75%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
75%
Aroon
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
IMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INSM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DCHRF0.04N/A
N/A
DISCOVERY HARBOUR RES CORP.
GMDMF0.04N/A
N/A
Gem Diamonds Ltd.
COCSF8.55N/A
N/A
Coca-Cola FEMSA S.A.B de CV
WAWIF9.30-0.04
-0.43%
Wallenius Wilhelmsen ASA
RSGUF4.15-0.04
-0.86%
Rogers Sugar Inc.

IMRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMRX has been loosely correlated with NUVL. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if IMRX jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMRX
1D Price
Change %
IMRX100%
+1.50%
NUVL - IMRX
35%
Loosely correlated
-0.82%
SRRK - IMRX
31%
Poorly correlated
N/A
ENTBF - IMRX
31%
Poorly correlated
N/A
INSM - IMRX
30%
Poorly correlated
+0.42%
DNA - IMRX
29%
Poorly correlated
-6.31%
More

INSM and

Correlation & Price change

A.I.dvisor indicates that over the last year, INSM has been closely correlated with THAR. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if INSM jumps, then THAR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INSM
1D Price
Change %
INSM100%
+0.42%
THAR - INSM
76%
Closely correlated
-2.35%
NWPHF - INSM
49%
Loosely correlated
N/A
AGIO - INSM
45%
Loosely correlated
+0.88%
CARM - INSM
44%
Loosely correlated
-1.62%
CRNX - INSM
41%
Loosely correlated
N/A
More